Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products Licensing

Dáil Éireann Debate, Tuesday - 22 September 2015

Tuesday, 22 September 2015

Ceisteanna (790, 791)

Michael Healy-Rae

Ceist:

790. Deputy Michael Healy-Rae asked the Minister for Health the reason the drug roaccutane, that according to the Health Products Regulatory Authority records has caused at least three fatalities, numerous mental and physical health injuries is allowed maintain its licence and continue to be prescribed; and if he will make a statement on the matter. [30697/15]

Amharc ar fhreagra

Michael Healy-Rae

Ceist:

791. Deputy Michael Healy-Rae asked the Minister for Health if he is aware of the purpose for which the drug roaccutane was developed; if he has requested this information from a pharmaceutical company (details supplied); if any employees of the Health Products Regulatory Authority have knowledge of this; and if he will make a statement on the matter. [30698/15]

Amharc ar fhreagra

Freagraí scríofa

I propose to take Questions Nos. 790 and 791 together.

I refer the Deputy to my composite reply 19166/15 of 19 May which provides a detailed reply to the questions asked by the Deputy.

Barr
Roinn